Showing results (71-80 of 234) with videos related to
Sort By:
Pageof 24
Neuromuscular Disorders : NMD|July 1, 1997
Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?S D Wilton, D E Dye, L M Blechynden, et al.FEBS Letters|December 21, 2018
YAPping about and not forgetting TAZBernard A Callus, Megan L Finch-Edmondson, Sue Fletcher, et al.Journal of Clinical Microbiology|January 1, 1992
Use of polymerase chain reaction for rapid diagnosis of tuberculosisD V Cousins, S D Wilton, B R Francis, et al.Journal of Cellular and Molecular Medicine|January 22, 2011
Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafishJoachim Berger, Silke Berger, Arie S Jacoby, et al.The Clinical Biochemist. Reviews|September 14, 2011
Molecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapiesNigel G Laing, Mark R Davis, Klair Bayley, et al.Mineralium Deposita|October 27, 2023
Characterizing the supra- and subsolidus processes that generated the Current PGE-Cu-Ni deposit, Thunder Bay North Intrusive Complex, Canada: insights from trace elements and multiple S isotopes of sulfidesM Brzozowski, P Hollings, G Heggie, et al.American Journal of Veterinary Research|June 22, 1999
Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy alleleK Honeyman, K S Carville, J M Howell, et al.Neuromuscular Disorders : NMD|April 12, 2001
Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophyS Fletcher, T Ly, R M Duff, et al.Expert Opinion on Biological Therapy|November 3, 2016
Translational development of splice-modifying antisense oligomersS Fletcher, M I Bellgard, L Price, et al.Molecular Therapy. Nucleic Acids|June 3, 2018
Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 TranscriptLoren L Flynn, Chalermchai Mitrpant, Ianthe L Pitout, et al.Pageof 24